591 related articles for article (PubMed ID: 29236692)
1. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.
Yang H; Jiang X; Li B; Yang HJ; Miller M; Yang A; Dhar A; Pavletich NP
Nature; 2017 Dec; 552(7685):368-373. PubMed ID: 29236692
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates.
Chao LH; Avruch J
F1000Res; 2019; 8():. PubMed ID: 30647914
[TBL] [Abstract][Full Text] [Related]
3. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K
J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883
[TBL] [Abstract][Full Text] [Related]
4. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1.
Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S
Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892
[TBL] [Abstract][Full Text] [Related]
5. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.
Sato T; Nakashima A; Guo L; Tamanoi F
J Biol Chem; 2009 May; 284(19):12783-91. PubMed ID: 19299511
[TBL] [Abstract][Full Text] [Related]
6. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
Wang L; Harris TE; Roth RA; Lawrence JC
J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057
[TBL] [Abstract][Full Text] [Related]
7. Intestinal cell kinase (ICK) promotes activation of mTOR complex 1 (mTORC1) through phosphorylation of Raptor Thr-908.
Wu D; Chapman JR; Wang L; Harris TE; Shabanowitz J; Hunt DF; Fu Z
J Biol Chem; 2012 Apr; 287(15):12510-9. PubMed ID: 22356909
[TBL] [Abstract][Full Text] [Related]
8. mTOR kinase structure, mechanism and regulation.
Yang H; Rudge DG; Koos JD; Vaidialingam B; Yang HJ; Pavletich NP
Nature; 2013 May; 497(7448):217-23. PubMed ID: 23636326
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells.
Peng H; Kasada A; Ueno M; Hoshii T; Tadokoro Y; Nomura N; Ito C; Takase Y; Vu HT; Kobayashi M; Xiao B; Worley PF; Hirao A
Biochem Biophys Res Commun; 2018 Jan; 495(1):1129-1135. PubMed ID: 29175333
[TBL] [Abstract][Full Text] [Related]
10. [New structures of mTORC1: Focus on Rag GTPases].
Nawrotek A; Cherfils J
Med Sci (Paris); 2021 Apr; 37(4):372-378. PubMed ID: 33908855
[TBL] [Abstract][Full Text] [Related]
11. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.
Fonseca BD; Smith EM; Lee VH; MacKintosh C; Proud CG
J Biol Chem; 2007 Aug; 282(34):24514-24. PubMed ID: 17604271
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling.
Rapley J; Oshiro N; Ortiz-Vega S; Avruch J
J Biol Chem; 2011 Nov; 286(44):38043-38053. PubMed ID: 21914810
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided mutation of the conserved G3-box glycine in Rheb generates a constitutively activated regulator of mammalian target of rapamycin (mTOR).
Mazhab-Jafari MT; Marshall CB; Ho J; Ishiyama N; Stambolic V; Ikura M
J Biol Chem; 2014 May; 289(18):12195-201. PubMed ID: 24648513
[TBL] [Abstract][Full Text] [Related]
14. Amino acid regulation of TOR complex 1.
Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678
[TBL] [Abstract][Full Text] [Related]
15. Architecture of human Rag GTPase heterodimers and their complex with mTORC1.
Anandapadamanaban M; Masson GR; Perisic O; Berndt A; Kaufman J; Johnson CM; Santhanam B; Rogala KB; Sabatini DM; Williams RL
Science; 2019 Oct; 366(6462):203-210. PubMed ID: 31601764
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays.
Shams R; Ito Y; Miyatake H
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445471
[TBL] [Abstract][Full Text] [Related]
17. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the docking of mTORC1 on the lysosomal surface.
Rogala KB; Gu X; Kedir JF; Abu-Remaileh M; Bianchi LF; Bottino AMS; Dueholm R; Niehaus A; Overwijn D; Fils AP; Zhou SX; Leary D; Laqtom NN; Brignole EJ; Sabatini DM
Science; 2019 Oct; 366(6464):468-475. PubMed ID: 31601708
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
Dunlop EA; Dodd KM; Seymour LA; Tee AR
Cell Signal; 2009 Jul; 21(7):1073-84. PubMed ID: 19272448
[TBL] [Abstract][Full Text] [Related]
20. Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells.
Ahmed AR; Owens RJ; Stubbs CD; Parker AW; Hitchman R; Yadav RB; Dumoux M; Hawes C; Botchway SW
Sci Rep; 2019 Mar; 9(1):3408. PubMed ID: 30833605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
